Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
≤0.016 - ? |
Triclosan |
186 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
0.25 - ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1579 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
0.25 - ? |
Vancomycin (Vancocyn, Lyphocin) |
186 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
1 - 2 |
A-80915A |
1001 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
1 - ? |
Telavancin (TD-6424, Vibativ) |
209 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
1 - ? |
Vancomycin (Vancocyn, Lyphocin) |
1502 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
2 - ? |
A-80915B |
1001 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
2 - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
269 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
2 - ? |
Vancomycin (Vancocyn, Lyphocin) |
269 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
8 - 16 |
Amikacin (Amikin) |
1502 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
8 - ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
186 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
16 - 32 |
Pexiganan |
14 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
64 - ? |
Nafcillin (Unipen, Nafcil) |
269 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
125 - ? |
Neomycin B |
1502 |